Search research articles
Contact Us
Filters
Showing results (281-290 of 525) with videos related to
Page
of 53
Sort By:
Plos One
|
October 28, 2015
Combinations of PARP Inhibitors with Temozolomide Drive PARP1 Trapping and Apoptosis in Ewing's Sarcoma
Sonja J Gill, Jon Travers, Irina Pshenichnaya, et al.
Circulation
|
May 1, 1991
Effects of physical conditioning on fibrinolytic variables and fibrinogen in young and old healthy adults
J R Stratton, W L Chandler, R S Schwartz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 17, 2001
Germline mutations in BRCA1 and BRCA2 in breast-ovarian families from a breast cancer risk evaluation clinic
A M Martin, M A Blackwood, D Antin-Ozerkis, et al.
Mabs
|
June 29, 2023
Modifying antibody-FcRn interactions to increase the transport of antibodies through the blood-brain barrier
Jason Tien, Dmitri Leonoudakis, Ralitsa Petrova, et al.
Archives of Toxicology
|
September 5, 2020
Mutagenicity of acrylamide and glycidamide in human TP53 knock-in (Hupki) mouse embryo fibroblasts
Lisa Hölzl-Armstrong, Jill E Kucab, Sarah Moody, et al.
The American Journal of Physiology
|
June 1, 1990
Effect of exercise on insulin action, glucose tolerance, and insulin secretion in aging
S E Kahn, V G Larson, J C Beard, et al.
Gastroenterology
|
March 26, 1999
Inherited susceptibility to colorectal adenomas and carcinomas: evidence for a new predisposition gene on 15q14-q22
I Tomlinson, N Rahman, I Frayling, et al.
Genes, Chromosomes & Cancer
|
June 15, 2010
GLO1-A novel amplified gene in human cancer
Thomas Santarius, Graham R Bignell, Chris D Greenman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 15, 2002
BRCA1 and BRCA2 mutation frequency in women evaluated in a breast cancer risk evaluation clinic
Helen A Shih, Fergus J Couch, Katherine L Nathanson, et al.
British Journal of Cancer
|
February 22, 2000
Lobular carcinoma in situ of the breast is not caused by constitutional mutations in the E-cadherin gene
N Rahman, J G Stone, G Coleman, et al.
Page
of 53
Search research articles
Search
Showing results (281-290 of 525) with videos related to
Sort By:
Page
of 53
Plos One
|
October 28, 2015
Combinations of PARP Inhibitors with Temozolomide Drive PARP1 Trapping and Apoptosis in Ewing's Sarcoma
Sonja J Gill, Jon Travers, Irina Pshenichnaya, et al.
Circulation
|
May 1, 1991
Effects of physical conditioning on fibrinolytic variables and fibrinogen in young and old healthy adults
J R Stratton, W L Chandler, R S Schwartz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 17, 2001
Germline mutations in BRCA1 and BRCA2 in breast-ovarian families from a breast cancer risk evaluation clinic
A M Martin, M A Blackwood, D Antin-Ozerkis, et al.
Mabs
|
June 29, 2023
Modifying antibody-FcRn interactions to increase the transport of antibodies through the blood-brain barrier
Jason Tien, Dmitri Leonoudakis, Ralitsa Petrova, et al.
Archives of Toxicology
|
September 5, 2020
Mutagenicity of acrylamide and glycidamide in human TP53 knock-in (Hupki) mouse embryo fibroblasts
Lisa Hölzl-Armstrong, Jill E Kucab, Sarah Moody, et al.
The American Journal of Physiology
|
June 1, 1990
Effect of exercise on insulin action, glucose tolerance, and insulin secretion in aging
S E Kahn, V G Larson, J C Beard, et al.
Gastroenterology
|
March 26, 1999
Inherited susceptibility to colorectal adenomas and carcinomas: evidence for a new predisposition gene on 15q14-q22
I Tomlinson, N Rahman, I Frayling, et al.
Genes, Chromosomes & Cancer
|
June 15, 2010
GLO1-A novel amplified gene in human cancer
Thomas Santarius, Graham R Bignell, Chris D Greenman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 15, 2002
BRCA1 and BRCA2 mutation frequency in women evaluated in a breast cancer risk evaluation clinic
Helen A Shih, Fergus J Couch, Katherine L Nathanson, et al.
British Journal of Cancer
|
February 22, 2000
Lobular carcinoma in situ of the breast is not caused by constitutional mutations in the E-cadherin gene
N Rahman, J G Stone, G Coleman, et al.
Page
of 53